SDHB: A Marker of Malignancy in Familial and Sporadic Pheochromocytomas/Sympathethic Paragangliomas

被引：0
|
作者：
Blank, A.
Schmitt, A. M.
Korpershoek, E.
van Nederveen, F. H.
Rudolph, T.
Weber, N.
Strebel, R.
de Krijger, R.
Komminoth, P.
Perren, A.
机构：
[1] Tech Univ Munich, Klinikum Rechts Isar, D-8000 Munich, Germany
[2] Univ Med Ctr, Josephine Nefkens Inst, Erasmus MC, Rotterdam, Netherlands
[3] Univ Zurich Hosp, Zurich, Switzerland
[4] Univ Bern, CH-3012 Bern, Switzerland
[5] City Hosp Triemli, Zurich, Switzerland
来源：
MODERN PATHOLOGY | 2011年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
559
引用
收藏
页码：134A / 134A
页数：1
相关论文
共 50 条
  • [21] Disentangling of Malignancy from Benign Pheochromocytomas/Paragangliomas
    Kim, Kyong Young
    Kim, Jung Hee
    Hong, A. Ram
    Seong, Moon-Woo
    Lee, Kyu Eun
    Kim, Su-Jin
    Kim, Sang Wan
    Shin, Chan Soo
    Kim, Seong Yeon
    PLOS ONE, 2016, 11 (12):
  • [22] Comparative Analysis of Scoring Systems and SDHB Expression in Pediatric Paragangliomas and Pheochromocytomas
    Gonzalez Roibon, Nilda
    Chaux, Alcides
    Felizzia, Guido
    D'Alessandro, Jimena
    Nespoli, Ezequiel
    Teresa de Davila, Maria
    Lubieniecki, Fabiana
    Galluzzo Mutti, Maria
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1876 - S1877
  • [23] Serum succinate as a marker of tumor metabolic burden in patients with 18F-FDG-PET positive sporadic or SDHB-mutated metastatic malignant pheochromocytomas/paragangliomas
    Tissot, H.
    Lamy, C.
    Faron, M.
    Paci, A.
    Baudin, E.
    Leboulleux, S.
    Hadoux, J.
    Broutin, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S138 - S139
  • [24] Is genetic screening indicated in apparently sporadic pheochromocytomas and paragangliomas?
    Iacobone, Maurizio
    Schiavi, Francesca
    Bottussi, Marzia
    Taschin, Elisa
    Bobisse, Sara
    Fassina, Ambrogio
    Opocher, Giuseppe
    Favia, Gennaro
    SURGERY, 2011, 150 (06) : 1194 - 1201
  • [25] Stathmin as a Marker for Malignancy in Pheochromocytomas
    Bjorklund, P.
    Cupisti, K.
    Fryknas, M.
    Isaksson, A.
    Willenberg, H. S.
    Akerstrom, G.
    Hellman, P.
    Westin, G.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2010, 118 (01) : 27 - 30
  • [26] The significance of SDHB immunohistochemistry and FISH analysis on pheochromocytomas and extra-adrenal paragangliomas
    Kimura, Noriko
    Saito, Jun
    Horii, Akira
    Ito, Sadayoshi
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2011, 28 : S20 - S20
  • [27] Evaluation of SDHB Immunohistochemistry in the Evaluation of Pheochromocytomas and Paragangliomas from Patients with and without Succinate Dehydrogenase B (SDHB) Mutations
    Fishbein, L.
    Nathanson, K.
    LiVolsi, V. A.
    Zhang, P. J.
    Montone, K. T.
    MODERN PATHOLOGY, 2011, 24 : 136A - 136A
  • [28] Evaluation of SDHB Immunohistochemistry in the Evaluation of Pheochromocytomas and Paragangliomas from Patients with and without Succinate Dehydrogenase B (SDHB) Mutations
    Fishbein, L.
    Nathanson, K.
    LiVolsi, V. A.
    Zhang, P. J.
    Montone, K. T.
    LABORATORY INVESTIGATION, 2011, 91 : 136A - 136A
  • [29] Surgical concept in sporadic and familial pheochromocytomas
    Goretzki, PE
    Simon, D
    Rober, HD
    ZENTRALBLATT FUR CHIRURGIE, 1997, 122 (06): : 467 - 472
  • [30] Germline SDHB mutations are common in patients with apparently sporadic sympathetic paragangliomas
    Klein, Roger D.
    Jin, Long
    Rumilla, Kandelaria
    Young, William F., Jr.
    Lloyd, Ricardo V.
    DIAGNOSTIC MOLECULAR PATHOLOGY, 2008, 17 (02) : 94 - 100
12345